The Kalamazoo-based medical device maker announced Oct. 16 it is purchasing Surpass Medical, Ltd., for $135 million. Stryker will pay $100 million in cash for the privately held company, with up to $35 million in additional milestone payments.
A small non-randomised study, led by Ronen R Leker, Hebrew University Hadassah Medical Centre, Jerusalem, Israel, published in Stroke, indicates that in patients with proximal middle cerebral artery occlusion (pMCOA), stent-based thrombectomy may be associated with more favourable outcomes than intravenous tissue plasminogen activator (tPA).
Scientists in Canada have found that a drug called NA-1 results in fewer brain lesions in patients who have undergone surgery to repair brain aneurysms, compared to placebo, and appears to be safe to use. The study has been published online in The Lancet Neurology.
If you eat plenty of tomatoes your risk of having a stroke will probably be lower, scientists from the University of Eastern Finland in Kuopio revealed in the October 9th issue of Neurology. The authors added that lycopene, an antioxidant in tomatoes, appears to have the stroke-prevention benefits.
St Jude Medical has announced the publication of results from the first large scale study of peripheral nerve stimulation (PNS) of the occipital nerves in patients suffering from chronic migraine. The study results, published online by Cephalalgia the journal of the International Headache Society, show a significant reduction in pain, headache days and migraine-related disability.
A new Mayo Clinic study confirms the use of smartphones medical images to evaluate patients in remote locations through telemedicine. The study, the first to test the effectiveness of smartphone teleradiology applications in a real-world telestroke network, was recently published in Stroke, a journal of the American Heart Association.
Over the past two decades, computer simulation has become an increasingly important tool in scientific research and engineering design. In the aerospace industry for example, simulation has become the standard tool for predicting performance of a newly designed part, well before the part is physically built. In clinical medicine, computer simulation is emerging as a viable option for surgical training and planning. For example, neurosurgical simulators now allow a user to navigate a catheter through challenging patient-specific anatomy and to deploy different endovascular devices including coils, stents, and flow diverters. These new simulators represent an important breakthrough in advancing surgical training toward life-like realism, and medical device companies have also begun to use them for demonstrating the deployment of emerging endovascular devices.
MRI Interventions and Brainlab AG have announced the first two cases performed in Europe with the ClearPoint Neuro Intervention System.
Home delivery of stroke rehabilitation improves care, eliminates waiting lists for treatment and saves hundreds of thousands of dollars annually in hospital costs, according to a quality improvement project presented at the Canadian Stroke Congress.
Medical residents training to work in the emergency department need more formal stroke training, says a study presented at the Canadian Stroke Congress, noting that, as the first point of contact in stroke care, they see nearly 100 per cent of stroke patients taken to hospital.
A new anticoagulant called apixaban is superior to warfarin in preventing stroke with consistent effects across a wide range of stroke and bleeding risk in patients with atrial fibrillation, according to Duke University Medical Center researchers.
A study published ahead-of-print in Stroke has identified risk factors for the increased risk of stroke with percutaneous transluminal angioplasty and stenting (PTAS) that was seen in the SAMMPRIS (Stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis) study. However, if all patients with these risk factors were excluded from receiving intracranial stenting, only a small subset of patients would remain.
St Jude Medical has announced it has received the CE mark approval for its Eon family of neurostimulators for patients with intractable chronic migraine. The approval includes the Eon Mini neurostimulator, which, according to St Jude, is the world’s smallest rechargeable neurostimulator with the longest-lasting battery in its class, and the Eon and EonC neurostimulators.
Bristol-Myers Squibb and Pfizer have announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of apixaban (Eliquis) for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation and one or more risk factors for stroke.
Results from IST-3, published in The Lancet in May and presented at the European Stroke Conference in Lisbon, found that for the type of patients recruited, despite the early hazards, thrombolysis within six hours improved functional outcome in acute ischaemic stroke patients. The international, randomised, controlled trial also shed light on the effects of alteplase on an older patient population.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos